126 related articles for article (PubMed ID: 2142087)
1. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
Bralet J; Mossiat C; Lecomte JM; Charpentier S; Gros C; Schwartz JC
Eur J Pharmacol; 1990 Apr; 179(1-2):57-64. PubMed ID: 2142087
[TBL] [Abstract][Full Text] [Related]
2. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
Lecomte JM; Baumer P; Lim C; Duchier J; Cournot A; Dussaule JC; Ardaillou R; Gros C; Chaignon B; Souque A
Eur J Pharmacol; 1990 Apr; 179(1-2):65-73. PubMed ID: 2163851
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
Gros C; Souque A; Schwartz JC
Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086
[TBL] [Abstract][Full Text] [Related]
5. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
Bralet J; Mossiat C; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
[TBL] [Abstract][Full Text] [Related]
6. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Gros C; Noël N; Souque A; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Lecomte JM; Bralet J
Proc Natl Acad Sci U S A; 1991 May; 88(10):4210-4. PubMed ID: 1851998
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
Bousselmame R; Eustache M; Michael-Titus A; Costentin J
Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents.
Shepperson NB; Barclay PL; Bennett JA; Samuels GM
Clin Sci (Lond); 1991 Mar; 80(3):265-9. PubMed ID: 1850687
[TBL] [Abstract][Full Text] [Related]
9. Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Gros C; Souque A; Schwartz JC
Neuropeptides; 1990 Sep; 17(1):1-5. PubMed ID: 2148814
[TBL] [Abstract][Full Text] [Related]
10. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
[TBL] [Abstract][Full Text] [Related]
12. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
[TBL] [Abstract][Full Text] [Related]
13. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
[TBL] [Abstract][Full Text] [Related]
14. Renal dopamine not renal nerve mediates diuretic and natriuretic effect of ANF in rats.
Kau MM; Huang WC
Chin J Physiol; 1991; 34(3):317-31. PubMed ID: 1839729
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition.
Hirata Y; Matsuoka H; Hayakawa H; Sugimoto T; Suzuki E; Sugimoto T; Kangawa K; Matsuo H
Hypertension; 1991 Jun; 17(6 Pt 2):1025-32. PubMed ID: 1828456
[TBL] [Abstract][Full Text] [Related]
16. Atriopeptin regulation and renal function in conscious spontaneously hypertensive rats.
Koepke JP; Tyler LD; Mehta PP; Olins GM; Trapani AJ; Hartupee DA; Bovy PR; Spear KL; Blaine EH
Am J Hypertens; 1990 Aug; 3(8 Pt 1):622-7. PubMed ID: 2171564
[TBL] [Abstract][Full Text] [Related]
17. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
18. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.
Vesely DL; Douglass MA; Dietz JR; Gower WR; McCormick MT; Rodriguez-Paz G; Schocken DD
Circulation; 1994 Sep; 90(3):1129-40. PubMed ID: 8087923
[TBL] [Abstract][Full Text] [Related]
19. Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications.
Schwartz JC; Gros C; Lecomte JM; Bralet J
Life Sci; 1990; 47(15):1279-97. PubMed ID: 2146457
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute renal denervation and ANF on renal function in adult spontaneously hypertensive rats.
Pollock DM; Arendshorst WJ
Am J Physiol; 1991 Oct; 261(4 Pt 2):R835-41. PubMed ID: 1833989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
